Archive for the ‘total’ tag
Crestor – TV commercial
Description: A man talks on-screen about the dangers of high cholesterol that may cause plaque buildup. He then invites viewers to visit Arterytour.com to get additional information via their interactive online tour. Arterytour.com is a comprehensive sales-pitch site for Crestor. Whats new about this site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.
Click here to visit the site.
To see all of the ads from this campaign, click here
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009
To see all Crestor ads, click here
From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Crestor – Arterytour.com site
Learn about high cholesterol and plaque buildup. Take an interactive artery tour.
Description: This is a very elaborate site on the risks associated with high cholesterol and plaque buildup. It also is a comprehensive sales-pitch for Crestor. Whats new about this Crestor site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.
Click here to visit the site.
To see all of the ads from this campaign, click here
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Internet
Publication: 2009
To see all Crestor ads, click here
From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Crestor – Building your life TV commercial
Description: People from different walks of life talk about cholesterol and how much they thought they knew about it and in reality they don’t. A spokesperson then comes in and talks about the risks associated with high cholesterol and its link with plaque buildup using animated visuals…
To see all of the ads from this campaign, click here
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009
To see all Crestor ads, click here
From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Crestor – Building your life TV commercials
Click here to see the details and full-size versions of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Crestor – little secret
“My diabetes and high cholesterol share an ugly little secret.”
Diabetes and high cholesterol increase the risk of plaque buildup in arteries. That's why it's so important to manage your cholesterol.
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
In 2008, research emerged that rosuvastatin could reduce the risk of heart attack, stroke, and other vascular complications in patients with elevated C-reactive protein but no other risk factors. This could strongly impact medical practice by placing many patients on statin prophylaxis that otherwise would have been untreated.
The results of the JUPITER trial suggested that rosuvastatin may decrease the relative risk of heart attack and stroke in patients without hyperlipidemia.
The AURORA trial randomized 2776 patients undergoing hemodialysis to receive either rosuvastatin or placebo. The randomized, double-blind study found no difference in the two groups in the primary end point, a combination of cardiovascular mortality, nonfatal myocardial infarction, or nonfatal stroke. The study found no difference in all-cause mortality among this population at a mean follow up of 3.8 years.
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Print ad
Size/duration: single-page
Publication: Diabetic Living – Fall 2009
To see all Crestor ads, click here
1 views
Sep 07, 2009
Visit AdPharm.net for more pharmaceutical ads
Crestor – Take action
“Now that I know how plaque can build in my arteries, I'm ready to Take Action.”
Get a Take Action kit to learn about high cholesterol and plaque buildup in arteries -and discover how Crestor can help.
Sig up for a Take Action Kit and get a 30-day free trial offer for Crestor. Go to TakeAction.com today.
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
In 2008, research emerged that rosuvastatin could reduce the risk of heart attack, stroke, and other vascular complications in patients with elevated C-reactive protein but no other risk factors. This could strongly impact medical practice by placing many patients on statin prophylaxis that otherwise would have been untreated.
The results of the JUPITER trial suggested that rosuvastatin may decrease the relative risk of heart attack and stroke in patients without hyperlipidemia.
The AURORA trial randomized 2776 patients undergoing hemodialysis to receive either rosuvastatin or placebo. The randomized, double-blind study found no difference in the two groups in the primary end point, a combination of cardiovascular mortality, nonfatal myocardial infarction, or nonfatal stroke. The study found no difference in all-cause mortality among this population at a mean follow up of 3.8 years.
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Print ad
Size/duration: single-page plus one-third
Publication: Heart Healthy Living – Fall 2009
To see all Crestor ads, click here
1 views
Sep 07, 2009
Visit AdPharm.net for more pharmaceutical ads
Crestor – Are you at risk?
“I didn’t realize my high cholesterol put me at risk for plaque buildup in my arteries.”
Are you at risk?
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Direct-to-Consumer (DTC)
Medium: Print ad
Size/duration: double-page spread
Publication: Prevention – October 2009
To see all Crestor ads, click here
